Evolocumab Reduces Oxidative Stress and Lipid Peroxidation in Obese Zucker Rats
<b>Background/Objectives</b>: Evolocumab inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9) binding to low-density lipoprotein (LDL) receptors, thus allowing more LDL receptors to remove LDL cholesterol from the blood. We aimed to determine the effects of evolocumab on the plasma lipid p...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI AG
2025-01-01
|
| Serier: | Pathophysiology |
| Fag: | |
| Online adgang: | https://www.mdpi.com/1873-149X/32/1/5 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
